Orbimed Advisors LLC Repare Therapeutics Inc. Transaction History
Orbimed Advisors LLC
- $2.93 Billion
- Q3 2025
A detailed history of Orbimed Advisors LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,322,488 shares of RPTX stock, worth $5.48 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,322,488
Previous 3,322,488
-0.0%
Holding current value
$5.48 Million
Previous $4.62 Million
26.61%
% of portfolio
0.2%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
49Shares Held
30.3MCall Options Held
158KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$17.1 Million0.98% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.68 Million2.63% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.9 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.37 Million7.6% of portfolio
-
Redmile Group, LLC San Francisco, CA1.59MShares$2.62 Million0.31% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $69.2M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...